Literature DB >> 28550204

Cutting Edge: Origins, Recruitment, and Regulation of CD11c+ Cells in Inflamed Islets of Autoimmune Diabetes Mice.

Joanna E Klementowicz1, Ashley E Mahne1, Allyson Spence1, Vinh Nguyen1, Ansuman T Satpathy2, Kenneth M Murphy3, Qizhi Tang4.   

Abstract

In NOD mice, CD11c+ cells increase greatly with islet inflammation and contribute to autoimmune destruction of pancreatic β cells. In this study, we investigated their origin and mechanism of recruitment. CD11c+ cells in inflamed islets resembled classical dendritic cells based on their transcriptional profile. However, the majority of these cells were not from the Zbtb46-dependent dendritic-cell lineage. Instead, monocyte precursors could give rise to CD11c+ cells in inflamed islets. Chemokines Ccl5 and Ccl8 were persistently elevated in inflamed islets and the influx of CD11c+ cells was partially dependent on their receptor Ccr5. Treatment with islet Ag-specific regulatory T cells led to a marked decrease of Ccl5 and Ccl8, and a reduction of monocyte recruitment. These results implicate a monocytic origin of CD11c+ cells in inflamed islets and suggest that therapeutic regulatory T cells directly or indirectly regulate their influx by altering the chemotactic milieu in the islets.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28550204      PMCID: PMC5501182          DOI: 10.4049/jimmunol.1601062

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.

Authors:  C Blanpain; I Migeotte; B Lee; J Vakili; B J Doranz; C Govaerts; G Vassart; R W Doms; M Parmentier
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

2.  Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study.

Authors:  Tatjana Nikolic; Sacha B Geutskens; Nico van Rooijen; Hemmo A Drexhage; Pieter J M Leenen
Journal:  Lab Invest       Date:  2005-04       Impact factor: 5.662

Review 3.  Re(de)fining the dendritic cell lineage.

Authors:  Ansuman T Satpathy; Xiaodi Wu; Jörn C Albring; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2012-11-16       Impact factor: 25.606

4.  Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice.

Authors:  Carla Carvalho-Pinto; María I García; Lucio Gómez; André Ballesteros; Angel Zaballos; Juana M Flores; Mario Mellado; José Miguel Rodríguez-Frade; Dimitrios Balomenos; Carlos Martínez-A
Journal:  Eur J Immunol       Date:  2004-02       Impact factor: 5.532

5.  CCR2 and CCR5 chemokine receptors differentially influence the development of autoimmune diabetes in the NOD mouse.

Authors:  Michelle Solomon; Balaji Balasa; Nora Sarvetnick
Journal:  Autoimmunity       Date:  2010-03       Impact factor: 2.815

6.  Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse.

Authors:  Javier A Carrero; Boris Calderon; Fadi Towfic; Maxim N Artyomov; Emil R Unanue
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

7.  CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

Authors:  Kristin V Tarbell; Sayuri Yamazaki; Kara Olson; Priscilla Toy; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

8.  The pancreas anatomy conditions the origin and properties of resident macrophages.

Authors:  Boris Calderon; Javier A Carrero; Stephen T Ferris; Dorothy K Sojka; Lindsay Moore; Slava Epelman; Kenneth M Murphy; Wayne M Yokoyama; Gwendalyn J Randolph; Emil R Unanue
Journal:  J Exp Med       Date:  2015-09-07       Impact factor: 14.307

9.  Deciphering the transcriptional network of the dendritic cell lineage.

Authors:  Jennifer C Miller; Brian D Brown; Tal Shay; Emmanuel L Gautier; Vladimir Jojic; Ariella Cohain; Gaurav Pandey; Marylene Leboeuf; Kutlu G Elpek; Julie Helft; Daigo Hashimoto; Andrew Chow; Jeremy Price; Melanie Greter; Milena Bogunovic; Angelique Bellemare-Pelletier; Paul S Frenette; Gwendalyn J Randolph; Shannon J Turley; Miriam Merad
Journal:  Nat Immunol       Date:  2012-07-15       Impact factor: 25.606

10.  The gene expression profile of CD11c+ CD8α- dendritic cells in the pre-diabetic pancreas of the NOD mouse.

Authors:  Wouter Beumer; Jojanneke M C Welzen-Coppens; Cornelia G van Helden-Meeuwsen; Sinead M Gibney; Hemmo A Drexhage; Marjan A Versnel
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

View more
  10 in total

Review 1.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

2.  Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE.

Authors:  Shalini Tanwar; Cihan Oguz; Amina Metidji; Eric Dahlstrom; Kent Barbian; Kishore Kanakabandi; Lydia Sykora; Ethan M Shevach
Journal:  J Autoimmun       Date:  2020-07-22       Impact factor: 7.094

3.  Allograft inflammatory factor-1 in myeloid cells drives autoimmunity in type 1 diabetes.

Authors:  Diana M Elizondo; Nailah Zd Brandy; Ricardo L da Silva; Tatiana R de Moura; Michael W Lipscomb
Journal:  JCI Insight       Date:  2020-05-21

4.  A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes.

Authors:  Khyati Girdhar; Qian Huang; I-Ting Chow; Tommi Vatanen; Claudia Brady; Amol Raisingani; Patrick Autissier; Mark A Atkinson; William W Kwok; C Ronald Kahn; Emrah Altindis
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-25       Impact factor: 12.779

5.  Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function.

Authors:  Anil Dangi; Irma Husain; Collin Z Jordan; Shuangjin Yu; Naveen Natesh; Xiling Shen; Jean Kwun; Xunrong Luo
Journal:  J Am Soc Nephrol       Date:  2022-08-16       Impact factor: 14.978

6.  MERTK on mononuclear phagocytes regulates T cell antigen recognition at autoimmune and tumor sites.

Authors:  Robin S Lindsay; Jennifer C Whitesell; Kristen E Dew; Erika Rodriguez; Adam M Sandor; Dayna Tracy; Seth F Yannacone; Brittany N Basta; Jordan Jacobelli; Rachel S Friedman
Journal:  J Exp Med       Date:  2021-08-20       Impact factor: 14.307

Review 7.  Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes.

Authors:  Farhan Ullah Khan; Puregmaa Khongorzul; Ahmed Aziz Raki; Ashwini Rajasekaran; Denis Gris; Abdelaziz Amrani
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

8.  CD11c+ Cells Are Gatekeepers for Lymphocyte Trafficking to Infiltrated Islets During Type 1 Diabetes.

Authors:  Adam M Sandor; Robin S Lindsay; Nathan Dyjack; Jennifer C Whitesell; Cydney Rios; Brenda J Bradley; Kathryn Haskins; David V Serreze; Aron M Geurts; Yi-Guang Chen; Max A Seibold; Jordan Jacobelli; Rachel S Friedman
Journal:  Front Immunol       Date:  2019-01-31       Impact factor: 7.561

9.  Neutral sphingomyelinase 2 regulates inflammatory responses in monocytes/macrophages induced by TNF-α.

Authors:  Fatema Al-Rashed; Zunair Ahmad; Reeby Thomas; Motasem Melhem; Ashley J Snider; Lina M Obeid; Fahd Al-Mulla; Yusuf A Hannun; Rasheed Ahmad
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

10.  Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes.

Authors:  Pavel N Zakharov; Hao Hu; Xiaoxiao Wan; Emil R Unanue
Journal:  J Exp Med       Date:  2020-06-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.